The Real Facts Behind Weight Loss Injections

By Dr Daniel Gordon • 20, Nov 2025


Weight Loss Injections: The Real Facts Behind Wegovy, Ozempic and Mounjaro

Every week in clinic, I meet people who have tried everything to lose weight: strict diets, endless gym plans, supplements that promised results. Then they hear about injections like Wegovy or Mounjaro and feel a sudden surge of hope. These treatments can change lives, but I’ve also seen how quickly hope can turn into confusion, frustration, or even harm when used without proper guidance.


This article is for anyone confused about weight loss injections. My aim is simple: to give you clear, evidence-based answers that cut through the noise.

People often arrive in clinic with the same questions and a lot of conflicting advice. So here are eight essential truths I share with my patients, based on real experience.

In this article you’ll learn:

  • What these medications are and how they work

  • When they’re helpful and when they’re not

  • What you need to watch out for to use them safely

By the end, you’ll understand the real facts about these treatments, not just the headlines.

Let’s begin.

Truth 1: The Semaglutide vs Tirzepatide Decode

Let’s start here, because this is where most of the confusion begins. The rise of these treatments has happened incredibly fast, and even doctors sometimes struggle to keep track.

The key thing to know: there are only two actual medications behind the big brand names everyone’s talking about.

Semaglutide is the older of the two. It comes under two brand names:

  • Ozempic: Licensed in the UK for treating type 2 diabetes. It was first used off‑label to support weight loss.

  • Wegovy: The same drug, semaglutide, but in a different injection pen and available in higher doses. This is the one officially licensed in the UK for weight management.

Tirzepatide is the newer option. It is branded in the UK as:

  • Mounjaro: Originally developed to treat type 2 diabetes. It is now also approved in the UK for weight management and has gained popularity for weight loss, particularly in the US.

All of these are part of a group of medicines called GLP-1 receptor agonists. They act on a hormone pathway that helps regulate appetite and metabolism.

Truth 2: Is Mounjaro Better Than Wegovy?

This is one of the most common questions I hear right now, and it’s a fair one.

The short answer is yes. Current evidence suggests that Mounjaro tends to produce greater weight loss than Wegovy.

So how big is the difference?

  • In clinical trials, people on Mounjaro lost 5 to 7% more of their body weight on average than those on Wegovy, over the course of about a year.

  • On Mounjaro, total weight loss could reach up to 20% of body weight.

  • On Wegovy, it was typically closer to 14%.

That is a significant difference, especially for patients with obesity or related health conditions.

Just as important, both medications appear to have similar safety and side effect profiles. So with Mounjaro, you may get more weight loss without a higher risk of side effects.

That said, biology isn’t always predictable. It is not one size fits all. I have seen patients do well on both.

The key is that both options are backed by strong evidence, and both can be highly effective when paired with proper lifestyle support.

Truth 3: How to Safely Get Wegovy or Mounjaro in the UK (And Avoid Dangerous Pitfalls)

This is where things become more complicated, and where people can genuinely get hurt.

There are only two legitimate ways to obtain these medicines in the UK:

  1. Through the NHS

  2. Through a regulated private service, such as a licensed health clinic or pharmacy

It is essential to understand this clearly. You should never buy these drugs from social media sellers, unverified websites, or any source that does not include a proper medical consultation with a qualified healthcare professional. You have no reliable way of knowing what you are actually buying.

There have already been cases of people being hospitalised and seriously harmed by counterfeit products falsely labelled as Wegovy or Mounjaro.

Access criteria are strict at the moment:

NHS access:

At the time of writing, Wegovy is usually available only through specialist weight management clinics. Mounjaro has recently been approved for GP prescribing under strict rules, typically requiring a BMI of 40 or above, or 37.5 or above for certain ethnic groups, and at least four out of five weight-related health problems such as type 2 diabetes, high blood pressure, or sleep apnoea.

Private access:

Criteria are less restrictive. Private doctors can prescribe if your BMI is above 30, or above 27.5 if you have even one weight-related condition.

If you are considering these medications, always do so under proper medical supervision. It is the only safe way to use them.

Truth 4: The Absolute Red Line Pregnancy and Contraception

This is one of the most important points to understand. If you are pregnant, breastfeeding, or planning to become pregnant, do not take these medications.

Studies in animals have shown clear signs of reproductive toxicity, meaning there is a real risk of harm to developing babies. Every manufacturer specifically warns against their use during pregnancy.

You also need to allow a washout period for the medicine to leave your body before trying to conceive. It is not as simple as stopping one day and starting a family the next. You must discuss your pregnancy plans with a qualified healthcare practitioner who is experienced in the prescription of GLP-1 injections.

Another key point that many people do not realise is that these drugs slow digestion, which can affect how the body absorbs other medicines including the oral contraceptive pill. This can make the pill less effective, and there have been reports of unintended pregnancies in the UK as a result.

If you are of childbearing age, this is a high-risk prescribing area. You must discuss contraception carefully with your prescriber and make sure you have reliable protection in place.

Do not guess, and do not take chances.

Truth 5: The Weight Regain Reality

This is one of the most honest and sometimes most difficult conversations I have with my patients.

People often ask, “Will I regain the weight when I stop taking the medication?”

The reality is yes. Most people will regain at least some of the weight after stopping. The evidence shows this is true for both Wegovy and Mounjaro.

However, that is not the whole story. I have seen many patients use their time on these medications as a reset; a period to build better habits, improve diet, increase physical activity, and rebuild confidence. For some, those changes help them maintain a significant part of their weight loss even after treatment ends.

And even if weight regain does occur, those months or years at a lower weight can still deliver meaningful health benefits:

  • Lower blood pressure

  • Better blood sugar control

  • Less strain on joints and the heart

The key is to plan ahead. Build the right habits and support while you are on the medication, and have a strategy in place for when you eventually stop.

Truth 6: Balancing Long-Term Benefits vs Short-Term Risks

Are these medications safe? It is a great question, and the honest answer is that we are still learning. We do not yet have 20, 30, or 40 years of follow-up data.

The short-term data, however, is reassuring. The most common side effects are mild to moderate, including:

  • Nausea

  • Vomiting

  • Diarrhoea

  • Constipation

These effects usually appear while the dose is increasing and tend to settle once the body adjusts.

Serious side effects are rare but can occur. These include gallstones and pancreatitis.

There is also a theoretical risk of thyroid cancer based on animal studies, which means anyone with a personal or family history of thyroid cancer may be advised by their healthcare professional to avoid these medications.

When deciding whether to take these treatments, the key is understanding that medicine is always a balance between benefit and risk.

If you are living with obesity, diabetes, or high blood pressure, your long-term health risks may already be substantial. In this case, the potential benefits of taking the medication may outweigh the risks. In other words, the cost of doing nothing can be higher than the risk of taking action.

If you have a healthy body mass index and no medical comorbidities, the balance can shift. The rarer risks may become harder to justify, which is why these medications should not be used purely for cosmetic weight loss.

In all cases the decision whether to take a weight loss injection or not should be made on a case-by-case and holistic basis, with the support of a healthcare professional who is experienced in the prescription, use and risks of the medications.

How Long Should You Use Wegovy or Mounjaro? What to Know Before You Start or Stop

This is the million-pound question, and the honest answer is that we do not fully know yet. There is no defined maximum duration in the research so far.

It is likely that many people will continue using these medications for obesity long term, possibly even indefinitely, much like we treat other chronic conditions such as high blood pressure.

The key is ongoing review to monitor safety, effectiveness, and suitability. Everyone needs an individualised plan that can evolve as new evidence emerges over the next few years.

To recap:

  • Wegovy and Ozempic contain semaglutide

  • Mounjaro contains tirzepatide

  • Mounjaro generally produces greater weight loss, but both are effective

  • These medicines should only be obtained through regulated medical services

  • They must never be used if you are pregnant or trying to conceive

I hope this has helped you feel clearer and more confident about the realities of these treatments.

Please remember that nothing here is personal medical advice. Everyone’s situation is different, and any treatment decision should be made with your own healthcare professional.

If you have used Wegovy or Mounjaro, or are thinking about starting, I would love to hear your experience.


Disclaimer

This blog post provides general information only. It is not intended to provide instruction and you should not rely on this information to determine a diagnosis, prognosis or course of treatment. It should not be used in place of a professional consultation with a doctor.

The medical information is the personal opinion of the stated author(s). It is based on available evidence or, where no published evidence is available, on current medical opinion and practice.

Every effort is taken to ensure that the information contained in this website is accurate and complete. However, accuracy cannot be guaranteed – rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate.

The author(s) is/are not responsible for the results of your decisions resulting from the use of the information, including, but not limited to, your choosing to seek or not to seek professional medical care, or from choosing or not choosing specific treatment based on the information.

You should not disregard the advice of your physician or other qualified healthcare provider because of any information you read on this website. If you have any health care questions, please consult a relevant medical practitioner.

Dr Daniel Gordon

Dr Daniel Gordon is a London-based GP with special interests in mental health and wellbeing, paediatrics and child health, chronic disease management and health screening.
———
Follow on Youtube, LinkedIn, Instagram, TikTok, & Facebook

Previous
Previous

A GP’s Guide to Propranolol for Anxiety

Next
Next

RSV Vaccine UK: Protecting Older Adults This Winter | DGA Health